primary immune deficiencies
Showing 1 - 25 of >10,000
Disorders With Increased Susceptibility to Fungal Infections
Recruiting
- Fungal Infections
- Primary Immune Deficiencies
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 18, 2023
Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,
Recruiting
- Primary Immune Deficiency Disorder
- +2 more
- Alemtuzumab
- +6 more
-
Baltimore, MarylandJohns Hopkins University
Oct 20, 2022
Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection, Chronic Granulomatous Disease Trial in Canada,
Completed
- Hemophagocytic Lymphohistiocytosis
- +5 more
- Hematopoietic Stem Cell Transplant
-
Birmingham, Alabama
- +21 more
Dec 6, 2022
COVID-19 Vaccine Responses in PIDD Subjects
Recruiting
- X-linked Agammaglobulinemia
- +6 more
-
Saint Petersburg, Florida
- +2 more
Apr 7, 2022
Individuals With and Without Immune Deficiencies and
Recruiting
- Immunodeficiencies
- Immune Dysregulations
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 6, 2023
Infections and Infection Susceptibility
Recruiting
- Immune Deficiencies
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Primary Antibody Deficiencies in Primary Care Facilities
Not yet recruiting
- Primary Antibody Deficiencies
- Blood withdrawal
-
Utrecht, NetherlandsUniversity Medical Center Utrecht
Mar 25, 2022
Iron Deficiency Anemia Trial in Nairobi (dietary supplement, biological, other)
Recruiting
- Iron Deficiency Anemia
- Iron supplementation
- +4 more
-
Nairobi, KenyaJomo Kenyatta University Of Agriculture And Technology
Oct 30, 2023
Immune-mediated Diseases
Recruiting
- Primary Immunodeficiency
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 10, 2023
Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])
Not yet recruiting
- Immune Thrombocytopenia
- Treatment
- Obinutuzumab Injection [Gazyva]
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital, Chinese Aca
Oct 17, 2023
ITP - Immune Thrombocytopenia Trial (hetrombopag 5mg po qd, High-dose Dexamethasone)
Not yet recruiting
- ITP - Immune Thrombocytopenia
- hetrombopag 5mg po qd
- High-dose Dexamethasone
- (no location specified)
Jul 5, 2023
Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction
Not yet recruiting
- Hiv
- +5 more
- differences in CD4 reconstruction
- (no location specified)
Sep 17, 2023
Pediatric Primary Immune Thrombocytopenia (ITP)
Recruiting
- Primary Immune Thrombocytopenia
- data collection
-
Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Oct 31, 2023
Iron Deficiency Anemia Trial in Msambweni (Oral iron supplementation (pre-treatment), COVID-19 vaccine, MenACWY vaccine)
Not yet recruiting
- Iron Deficiency Anemia
- Oral iron supplementation (pre-treatment)
- +3 more
-
Msambweni, KenyaMsambweni County Referral Hospital
Jun 16, 2023
Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)
Not yet recruiting
- Primary Immune Thrombocytopenia (ITP)
- Ianalumab
- (no location specified)
Jun 5, 2023
Immuno-Deficiency Trial in Caen (Systematic screening of immune deficiency)
Completed
- Immuno-Deficiency
- Systematic screening of immune deficiency
-
Caen, FranceCaen University Hospital
Nov 28, 2022
Primary Immune Thrombocytopenia Trial in Shandong (QL0911, Placebo comparator)
Completed
- Primary Immune Thrombocytopenia
- QL0911
- Placebo comparator
-
Shandong, ChinaQilu Hospital of Shandong University
Nov 20, 2022
Primary Immune Thrombocytopenia (ITP) Trial in Singapore (Ianalumab, Placebo, Corticosteroids)
Recruiting
- Primary Immune Thrombocytopenia (ITP)
- Ianalumab
- +2 more
-
Singapore, SingaporeNovartis Investigative Site
Jan 17, 2023
Bronchiectasis, Cystic Fibrosis, Primary Ciliary Dyskinesia Trial in Haifa (spirometry, Salbutamol, )
Recruiting
- Bronchiectasis
- +4 more
- spirometry
- +2 more
-
Haifa, IsraelRambam Health Campus
Jun 30, 2023
Primary Immune Regulatory Disorder, Autoimmune Lymphoproliferative, Immune System Diseases Trial in United States (Emapalumab,
Recruiting
- Primary Immune Regulatory Disorder
- +2 more
- Emapalumab
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Mar 15, 2023
Primary Immune Thrombocytopenia Trial in Singapore (Ianalumab, Eltrombopag, Placebo)
Recruiting
- Primary Immune Thrombocytopenia
- Ianalumab
- +2 more
-
Singapore, SingaporeNovartis Investigative Site
Jan 23, 2023
Intestinal Inflammation in People With Primary Immune
Recruiting
- Chronic Granulomatous Disease
- Inflammatory Bowel Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
SPAD in Adult Patients
Not yet recruiting
- Specific Antibody Deficiency
- Predominantly Antibody Deficiencies
- Diagnosis of SPAD using immunization with PPV23
- (no location specified)
Dec 15, 2022
Immune Thrombocytopenia Purpura Trial in Cairo (Dexamethasone, Prednisolone and Azathioprine, Rituximab)
Recruiting
- Immune Thrombocytopenia Purpura
- Dexamethasone
- +4 more
-
Cairo, EgyptEL-Kasr elineiy
May 6, 2023
Long COVID, POTS - Postural Orthostatic Tachycardia Syndrome, Autonomic Dysfunction Trial (IL-6, cytokines (IL-17, and IFN-?),
Not yet recruiting
- Long COVID
- +2 more
- IL-6
- +2 more
- (no location specified)
Sep 6, 2023